The CiMUS research groups listed below offer MSCA postdoctoral positions aligned with their research areas. Please find additional information about each group and the principal investigator (PI) through the provided links.
Are you interested in applying for a position? If so, please provide the information you will find in this document below (Application).
May you need additional information, please contact us at cimus [at] usc.es (cimus[at]usc[dot]es)
Mitochondrial Genetics & Cell Stress Signalling (mitophenomics-lab)
Mitochondrial diseases lead by mutations in mitochondrial (mtDNA) and nuclear (nDNA) genomes
Role in cancer biology of mitochondrial DNA (mtDNA) variants
Cell Cycle and Oncology (cell-cycle-and-oncology)
• Development of new therapeutic strategies against cancer
• Validation of new immunotherapeutic approaches to fight ovarian cancer
• Development of chemorresistant models of advanced cancer
• Molecular mechanisms of action of immune-mediated therapies in cancer
Brain Plasticity Laboratory (brain-plasticity)
• Role of endocrine factors in brain plasticity
Platelet Proteomics (platelet-proteomics)
• Drug Discovery in Antithrombotics
• Platelet Proteomics in obesity
• Extracellular vesicles (EVs) in health and disease
• Leukocyte and Platelet-rich fibrin (L-PRF) in regenerative medicine
Cell and Molecular Neurobiology of Parkinson's Disease (cell-and-molecular-neurobiology-parkinsons-disease)
• Early markers of Parkinson disease
• Basic research in Parkinson's disease
• Development of neuroprotective strategies
• Brain renin-angiotensin system
Epitranscriptomics & Ageing (epitranscriptomics-ageing)
• RNA modifications in ageing
• Crosstalk of RNA modifications and epigenetics
DNA Repair & Genome Integrity (dna-repair-and-genome-integrity)
• Regulation of DNA repair enzymes in eukaryotes
• Biochemical characterization of novel DNA repair activities
Biomaterials & Drug Delivery (biomaterials-drug-delivery)
• Advanced Nanoparticle-based RNA Therapy for Glioblastoma
Molecular Imaging Biomarkers and Theragnosis (molecular-imaging-biomarkers-and-theragnosis-lab)
• PET biomarkers in Alzheimer disease
• Theragnostic radiopharmaceuticals in brain tumours
• Imaging biomarkers in inflammatory diseases
• Imaging biomarkers in drug discovery
Cell signalling and stress lab & Vascular Biology lab (cell-signalling-and-stress) & (laboratory-vascular-biology)
• Stress kinases and glucose metabolism
• Stress kinases and cavernoma development
• Preclinical studies on cavernoma treatment
Cell senescence, cancer and aging (cell-senescence-cancer-and-aging)
• Rejuvenation as an anticancer strategy
• Identification and characterization of novel senolytic and senomorphic compounds
Gene Regulatory Control in Disease (cell-senescence-cancer-and-aging)
• Nerve Disorders: Schwann cell biology, ranging from axonal myelination to the response of Schwann cells to pathological conditions, including nerve injury, genetic disorders, immune cell attack and microbial infections.
• Cancer: Identification of therapeutical targets for neurofibromatosis type 1 and malignant peripheral nerve sheath tumours (MPNST)
Liver Metabolism and Disorders Laboratory (LiMED) (cell-senescence-cancer-and-aging)
• Liver Cancer (Cholangiocarcinoma). Molecular mechanisms involved in the development of cholangiocarcinoma, identifying biomarkers for early diagnosis and novel therapeutic strategies.
• Liver Regeneration. Integration of the metabolic processes and cell proliferation that underlie liver regeneration, exploring the potential therapeutic approaches to enhance the liver’s regenerative capacity after liver injury.
• Hepatic Fibrosis. Molecular mechanisms driving liver fibrosis.
• Hepatic Metabolism. Mechanisms of hepatic mitochondria adaption to different physiological states, and metabolic dysregulation in MAFLD).
Please contact for further information at cimus@usc.es